But Who’s Counting? Icahn Wins A Biogen Seat, Another Is “Too Close To Call”
Executive Summary
After a drama-packed shareholder meeting on June 3, Carl Icahn claims he won two of four contested seats on the 13-person, Biogen Idec board
You may also be interested in...
Agreement Averts Another Proxy Fight Between Biogen Idec, Icahn
Despite agreeing to support Biogen's nominee slate, Icahn says he still will push for biotech sale.
Agreement Averts Another Proxy Fight Between Biogen Idec, Icahn
Despite agreeing to support Biogen's nominee slate, Icahn says he still will push for biotech sale.
Court Date for Biogen and Elan Set for Sept. 3
The partners, who are litigating over Tysabri, face off earlier than expected.